These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36619673)

  • 21. GluN1 and GluN2A NMDA Receptor Subunits Increase in the Hippocampus during Memory Consolidation in the Rat.
    Cercato MC; Vázquez CA; Kornisiuk E; Aguirre AI; Colettis N; Snitcofsky M; Jerusalinsky DA; Baez MV
    Front Behav Neurosci; 2016; 10():242. PubMed ID: 28133447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors.
    Kolcheva M; Ladislav M; Netolicky J; Kortus S; Rehakova K; Krausova BH; Hemelikova K; Misiachna A; Kadkova A; Klima M; Chalupska D; Horak M
    Neuropharmacology; 2023 Jan; 222():109297. PubMed ID: 36341805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of rat recombinant GluN1/GluN2A and GluN1/GluN2B NMDA receptors by ethanol at concentrations based on the US/UK drink-drive limit.
    Otton HJ; Janssen A; O'Leary T; Chen PE; Wyllie DJ
    Eur J Pharmacol; 2009 Jul; 614(1-3):14-21. PubMed ID: 19394328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GluN2A Subunit-Containing NMDA Receptors Are the Preferential Neuronal Targets of Homocysteine.
    Sibarov DA; Abushik PA; Giniatullin R; Antonov SM
    Front Cell Neurosci; 2016; 10():246. PubMed ID: 27847466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
    Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
    Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the NMDA receptor by its cytoplasmic domains: (How) is the tail wagging the dog?
    Ishchenko Y; Carrizales MG; Koleske AJ
    Neuropharmacology; 2021 Sep; 195():108634. PubMed ID: 34097949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
    Hansen KB; Ogden KK; Yuan H; Traynelis SF
    Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Properties of Human NMDA Receptors Associated with Epilepsy-Related Mutations of GluN2A Subunit.
    Sibarov DA; Bruneau N; Antonov SM; Szepetowski P; Burnashev N; Giniatullin R
    Front Cell Neurosci; 2017; 11():155. PubMed ID: 28611597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity.
    Hughes BA; Woodward JJ
    Neuropharmacology; 2016 Jun; 105():96-105. PubMed ID: 26577016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease.
    Mohamed NE; Lee JH; Francis PT; Esiri MM; Chen CP; Lai MK
    J Alzheimers Dis; 2015; 44(2):431-7. PubMed ID: 25261450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist.
    McKay S; Griffiths NH; Butters PA; Thubron EB; Hardingham GE; Wyllie DJ
    Br J Pharmacol; 2012 Jun; 166(3):924-37. PubMed ID: 22022974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-function.
    Myers SJ; Yuan H; Perszyk RE; Zhang J; Kim S; Nocilla KA; Allen JP; Bain JM; Lemke JR; Lal D; Benke TA; Traynelis SF
    Hum Mol Genet; 2023 Sep; 32(19):2857-2871. PubMed ID: 37369021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity.
    Zhou X; Ding Q; Chen Z; Yun H; Wang H
    J Biol Chem; 2013 Aug; 288(33):24151-9. PubMed ID: 23839940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of GluN2A and GluN2B subunits in the formation of filopodia and secondary dendrites in cultured hippocampal neurons.
    Henle F; Dehmel M; Leemhuis J; Fischer C; Meyer DK
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):171-80. PubMed ID: 22033802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene Targeted Mice with Conditional Knock-In (-Out) of NMDAR Mutations.
    Sprengel R; Eltokhi A; Single FN
    Methods Mol Biol; 2017; 1677():201-230. PubMed ID: 28986875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neto1 associates with the NMDA receptor/amyloid precursor protein complex.
    Cousins SL; Innocent N; Stephenson FA
    J Neurochem; 2013 Sep; 126(5):554-64. PubMed ID: 23621516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sex and DTNBP1 (dysbindin) null gene mutation on the developmental GluN2B-GluN2A switch in the mouse cortex and hippocampus.
    Sinclair D; Cesare J; McMullen M; Carlson GC; Hahn CG; Borgmann-Winter KE
    J Neurodev Disord; 2016; 8():14. PubMed ID: 27134685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
    Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
    Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonistic action on NMDA/GluN2B mediated currents of two peptides that were conantokin-G structure-based designed.
    Reyes-Guzman EA; Vega-Castro N; Reyes-Montaño EA; Recio-Pinto E
    BMC Neurosci; 2017 May; 18(1):44. PubMed ID: 28511693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.